Page breadcrumb nav

VAERS Report 2156842

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fl9994


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-17
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

nausea; weakness of arms; headache; arm which received the injection felt very painful when raised it or pressed on the area of needle entry; inappropriate schedule of vaccine administered; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202191316130150-9shdb (ra). other case identifier(s): gb-mhra-adr 26625751 (ra). a 43 year-old male patient received bnt162b2 (comirnaty), administration date 17feb2022 (lot number: fl9994) as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. past drug history included: espranor, notes: espranor (buprenorphine) 10mg per day. vaccination history included: comirnaty (dose 1), administration date: 23dec2021, for covid-19 vaccination. the following information was reported: nausea (medically significant) with onset 18feb2022, outcome "recovered" (19feb2022), described as "nausea"; muscular weakness (medically significant) with onset 18feb2022, outcome "not recovered", described as "weakness of arms"; headache (medically significant) with onset 18feb2022, outcome "recovered" (19feb2022), described as "headache"; vaccination site pain (medically significant) with onset 18feb2022, outcome "unknown", described as "arm which received the injection felt very painful when raised it or pressed on the area of needle entry"; inappropriate schedule of product administration (non-serious) with onset 17feb2022, outcome "unknown", described as "inappropriate schedule of vaccine administered". clinical course: patient has not had symptoms associated with covid-19; not had a covid-19 test. patient reported to be fine all day following the injection on the 17feb2021. however, the following day patient woke up with a headache and feeling of nausea. patient would describe it as severe but became fairly mild after a few hours and remained in this condition for the entire day. also, his arm which received the injection felt very painful when raised it or pressed on the area of needle entry, more worryingly it was very weak (had virtually zero grip strength and the limb is too weak to lift a full cup of tea). today (discrepantly reported as 19th january) the headache and nausea feelings have vanished but arm has improved only very slightly and remains very weak. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial. if this condition doesn't improve before monday, 21feb, patient reported that he will attend gp's practice. no follow-up attempts are possible. no further information is expected

Données de laboratoire
na
Liste des symptômes
nausea headache muscular weakness inappropriate schedule of product administration vaccination site pain
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na